Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/VAXCYTE-INC-108367227/news/VAX-24-Phase-1-2-Adult-Proof-of-Concept-Data-Published-in-The-Lancet-Infectious-Diseases-Highlight-B-45497825/?utm_source=whatsapp&utm_medium=social&utm_campaign=share